Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
Explore this paper's citation graph
Summary
Tigecycline showed considerable, though not consistent, antimicrobial activity against MDR (including carbapenem-resistant) Acinetobacter spp.
- Type
- review
- Published
- 2008-07-01
- Cited by
- 204
- References
- 100
- Access
- Open access
- OpenAlex
- https://openalex.org/W2148134051
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:15067564
Keywords
Tigecycline, Acinetobacter, Acinetobacter baumannii, Medicine, Broth microdilution
References
- Antimicrobial resistance of Acinetobacter spp. in Europe.
- EUCAST technical note on tigecycline.
- TIGECYCLINE USE IN CRITICALLY ILL OLDER PATIENTS: CASE REPORTS AND CRITICAL ANALYSIS
- Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
- Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
- Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications.
- Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*
- Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
- Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
- Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study
- Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.
- Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
- In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
- Activity of Tigecycline (GAR-936) against Acinetobacter baumannii Strains, Including Those Resistant to Imipenem
- Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
- Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
- Clinical strains of Acinetobacter classified by DNA‐DNA hybridization
- Baseline in vitro Activity of Tigecycline among Key Bacterial Pathogens Exhibiting Multidrug Resistance
- In vitro activities of tigecycline against clinical isolates from Shanghai, China.
- Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.
Cited by
- Advances in antibacterial therapy against emerging bacterial pathogens.
- Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence.
- Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii.
- A Milk Pump as a Source for Spreading Acinetobacter baumannii in a Neonatal Intensive Care Unit
- Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?
- Development and Characterization of Monoclonal Antibodies for Rapid Detection of Acinetobacter baumannii
- Patrones de resistencia a antibióticos de Acinetobacter baumannii en un hospital de Colombia
- Hospital Acquired Antibiotic-Resistant Acinetobacter Baumannii Infections in a 400-Bed Hospital in Tehran, Iran
- A study on pattern of antimicrobial resistance in clinical isolates of acinetobacter spp at a tertiary care hospital
- Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
- Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
- Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: Susceptibility and clinical outcome
- In Vitro Activity of Tigecycline and Comparators Against Gram-Negative Bacteria Isolated from a Tertiary Hospital in Alexandria, Egypt
- Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital
- Multidrug-Resistant Gram-Negative Infections
- Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
- Multidrug-resistant organisms and antibiotic management.
- Acinetobacter species meningitis in children: a case series from Karachi, Pakistan.
- Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections.
- Therapeutic options for Acinetobacter baumannii infections: an update
Related papers
- Synergistic Role of Biofilm-Associated Genes and Efflux Pump Genes in Tigecycline Resistance of Acinetobacter baumannii
- In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran
- Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
- Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital
- Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii
- Resistance mechanisms of tigecycline in Acinetobacter baumannii
- Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
- Role of Efflux Pumps in Reduced Susceptibility to Tigecycline among Clinical Isolates of Acinetobacter baumannii
- Nationwide Surveillance of in vitro Activities of Tigecycline against Clinical Isolates of Gram-Positive Bacteria in Taiwan: Broth Microdilution Method vs. the E test